Venclexta® (venetoclax) – New warning
July 25, 2019 - The FDA approved an update to the Warnings and Precautions section of the Venclexta (venetoclax) drug label, regarding increased mortality in patients with multiple myeloma when Venclexta is added to Velcade® (bortezomib) and dexamethasone.
Download PDF
